Clinical Profile of Alzheimer's Disease: Is the Age of the Patient a Decisive Factor? Results of the INFLUENCE Study
作者： José L. Molinuevo , Ignacio Casado-Naranjo
DOI: 10.3233/JAD-131433
关键词: Dyslipidemia 、 Concomitant drug 、 Epidemiology 、 Disease 、 Stage (cooking) 、 Concomitant 、 Medicine 、 Gerontology 、 Internal medicine 、 Depression (differential diagnoses) 、 Dementia
摘要: Epidemiological and clinical studies suggest that dementia patients aged ≥ 85 years are biologically different from those 65-84. This study aimed to assess whether (>85 years) have a distinct sociodemographic profile. Older had lower educational achievements, carer relationships, were more likely take meman- tine/concomitant treatments be institutionalized. Differences observed with respect concomitant disease/other risk factors (depression, dyslipidemia, cardiovascular disease, hypertension). Oldest greater impairment (more severe Global Deterioration Scale stage, Mini-Mental State Examination scores). Greater drug use younger carers associated older higher management social costs.
sci-hub.se 参考文章(20)
Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. American Journal of Psychiatry. ,vol. 153, pp. 1438- 1443 ,(1996) , 10.1176/AJP.153.11.1438
Kristin Kahle-Wrobleski, Maria M. Corrada, Bixia Li, Claudia H. Kawas, Sensitivity and specificity of the mini-mental state examination for identifying dementia in the oldest-old: the 90+ study. Journal of the American Geriatrics Society. ,vol. 55, pp. 284- 289 ,(2007) , 10.1111/J.1532-5415.2007.01049.X
Carolyn W Zhu, Mary Sano, Economic considerations in the management of Alzheimer's disease. Clinical Interventions in Aging. ,vol. 1, pp. 143- 154 ,(2006) , 10.2147/CIIA.2006.1.2.143
Dominic Holland, Rahul S. Desikan, Anders M. Dale, Linda K. McEvoy, , Rates of Decline in Alzheimer Disease Decrease with Age PLoS ONE. ,vol. 7, pp. e42325- ,(2012) , 10.1371/JOURNAL.PONE.0042325
NH Stricker, Y-L Chang, C Fennema-Notestine, L Delano-Wood, DP Salmon, MW Bondi, AM Dale, Alzheimer's Disease Neuroimaging Initiative, Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease Neurology. ,vol. 77, pp. 713- 721 ,(2011) , 10.1212/WNL.0B013E31822B0004
Jesús de Pedro-Cuesta, Javier Virués-Ortega, Saturio Vega, Manuel Seijo-Martínez, Pedro Saz, Fernanda Rodríguez, Angel Rodríguez-Laso, Ramón Reñé, Susana Pérez de las Heras, Raimundo Mateos, Pablo Martínez-Martín, José María Manubens, Ignacio Mahillo-Fernandez, Secundino López-Pousa, Antonio Lobo, Jordi Llinàs Reglà, Jordi Gascón, Francisco José García, Manuel Fernández-Martínez, Raquel Boix, Félix Bermejo-Pareja, Alberto Bergareche, Julián Benito-León, Ana de Arce, Jose Luis Del Barrio, None, Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys, 1990-2008. BMC Neurology. ,vol. 9, pp. 55- 55 ,(2009) , 10.1186/1471-2377-9-55
Claudia Kawas, Maria Corrada, Alzheimer's and dementia in the oldest-old: a century of challenges. Current Alzheimer Research. ,vol. 3, pp. 411- 419 ,(2006) , 10.2174/156720506779025233
E. M. Ebly, I. M. Parhad, D. B. Hogan, T. S. Fung, Prevalence and types of dementia in the very old : results from the Canadian Study of Health and Aging Neurology. ,vol. 44, pp. 1593- 1593 ,(1994) , 10.1212/WNL.44.9.1593
A. F. Jorm, A. E. Korten, A. S. Henderson, The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatrica Scandinavica. ,vol. 76, pp. 465- 479 ,(1987) , 10.1111/J.1600-0447.1987.TB02906.X
MARK W. BONDI, WES S. HOUSTON, DAVID P. SALMON, JODY COREY-BLOOM, ROBERT KATZMAN, LEON J. THAL, DEAN C. DELIS, Neuropsychological deficits associated with Alzheimer's disease in the very-old: discrepancies in raw vs. standardized scores. Journal of The International Neuropsychological Society. ,vol. 9, pp. 783- 795 ,(2003) , 10.1017/S1355617703950119